HEADER OXIDOREDUCTASE 19-OCT-16 5TP6 TITLE SOLUTION STRUCTURE OF THE CAM34 WITH THE INOS CAM BINDING DOMAIN TITLE 2 PEPTIDE COMPND MOL_ID: 1; COMPND 2 MOLECULE: CALMODULIN; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: CAM; COMPND 5 ENGINEERED: YES; COMPND 6 MUTATION: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: NITRIC OXIDE SYNTHASE, INDUCIBLE; COMPND 9 CHAIN: B; COMPND 10 FRAGMENT: RESIDUES 507-531; COMPND 11 SYNONYM: HEPATOCYTE NOS,HEP-NOS,INDUCIBLE NO SYNTHASE,INOS,NOS TYPE COMPND 12 II,PEPTIDYL-CYSTEINE S-NITROSYLASE NOS2; COMPND 13 EC: 1.14.13.39; COMPND 14 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: CALM1, CALM, CAM, CAM1, CALM2, CAM2, CAMB, CALM3, CALML2, SOURCE 6 CAM3, CAMC, CAMIII; SOURCE 7 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 9 MOL_ID: 2; SOURCE 10 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 11 ORGANISM_COMMON: HUMAN; SOURCE 12 ORGANISM_TAXID: 9606; SOURCE 13 GENE: NOS2, NOS2A; SOURCE 14 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 15 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS CALCIUM DEFICIENT, NITRIC OXIDE SYNTHASE, OXIDOREDUCTASE EXPDTA SOLUTION NMR NUMMDL 20 AUTHOR M.PIAZZA,T.DIECKMANN,J.G.GUILLEMETTE REVDAT 3 01-MAY-24 5TP6 1 REMARK REVDAT 2 08-JAN-20 5TP6 1 REMARK REVDAT 1 27-SEP-17 5TP6 0 JRNL AUTH M.PIAZZA,V.TAIAKINA,T.DIECKMANN,J.G.GUILLEMETTE JRNL TITL STRUCTURAL CONSEQUENCES OF CALMODULIN EF HAND MUTATIONS. JRNL REF BIOCHEMISTRY V. 56 944 2017 JRNL REFN ISSN 1520-4995 JRNL PMID 28121131 JRNL DOI 10.1021/ACS.BIOCHEM.6B01296 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER, ADAMS, CLORE, GROS, NILGES AND READ REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5TP6 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 21-OCT-16. REMARK 100 THE DEPOSITION ID IS D_1000224587. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298 REMARK 210 PH : 6.0 REMARK 210 IONIC STRENGTH : 100 REMARK 210 PRESSURE : 1 ATM REMARK 210 SAMPLE CONTENTS : 1 MM [U-99% 13C; U-99% 15N] REMARK 210 CAM34, 1 MM INOS CAM BINDING REMARK 210 DOMAIN PEPTIDE, 100 MM POTASSIUM REMARK 210 CHLORIDE, 10 MM CALCIUM CHLORIDE, REMARK 210 0.2 MM SODIUM AZIDE, 90% H2O/10% REMARK 210 D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D 1H-15N HSQC; 3D HNCA; 3D HCCH REMARK 210 -TOCSY; 3D 1H-13C NOESY; 3D 1H- REMARK 210 15N NOESY; 2D 1H-15N DOUBLE REMARK 210 FILTERED NOESY REMARK 210 SPECTROMETER FIELD STRENGTH : 600 MHZ REMARK 210 SPECTROMETER MODEL : DRX REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : CNS, CARA REMARK 210 METHOD USED : SIMULATED ANNEALING REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 20 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 20 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LOWEST REMARK 210 ENERGY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 HZ1 LYS A 75 HH11 ARG B 530 1.26 REMARK 500 HG SER A 38 HD21 ASN A 111 1.27 REMARK 500 O ILE A 130 H GLY A 132 1.47 REMARK 500 O VAL A 121 HB ILE A 125 1.54 REMARK 500 OD1 ASN A 137 H TYR A 138 1.59 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 LEU A 4 -159.41 -99.22 REMARK 500 1 ASP A 20 93.52 -59.62 REMARK 500 1 PRO A 43 87.18 -64.08 REMARK 500 1 THR A 70 -18.37 -44.94 REMARK 500 1 ASN A 97 -74.66 -117.51 REMARK 500 1 ASP A 131 -33.23 55.14 REMARK 500 1 ARG B 507 100.83 57.05 REMARK 500 1 ARG B 511 -44.34 -136.93 REMARK 500 1 LYS B 516 32.67 35.08 REMARK 500 1 VAL B 517 -42.49 -147.02 REMARK 500 1 LEU B 518 -0.04 -58.83 REMARK 500 1 VAL B 519 -37.68 -140.53 REMARK 500 1 ARG B 530 34.69 -91.32 REMARK 500 2 ASP A 2 125.38 62.88 REMARK 500 2 PRO A 43 86.96 -69.39 REMARK 500 2 ASP A 95 -0.63 73.81 REMARK 500 2 ASP A 131 -70.07 57.02 REMARK 500 2 ARG B 510 131.69 63.35 REMARK 500 2 LEU B 515 -70.71 -79.38 REMARK 500 2 LYS B 516 34.65 34.04 REMARK 500 2 VAL B 517 -37.11 -145.69 REMARK 500 2 LEU B 518 5.25 -61.52 REMARK 500 2 VAL B 519 -35.03 -139.03 REMARK 500 3 PRO A 43 87.11 -63.21 REMARK 500 3 TYR A 99 118.81 -160.10 REMARK 500 3 ALA A 128 11.06 -143.33 REMARK 500 3 ASP A 131 -34.74 60.15 REMARK 500 3 LYS B 509 123.77 64.20 REMARK 500 3 ILE B 513 77.45 37.93 REMARK 500 3 LEU B 515 -75.83 -83.94 REMARK 500 3 LYS B 516 34.70 36.24 REMARK 500 3 VAL B 517 -39.18 -138.50 REMARK 500 3 LEU B 518 1.13 -61.79 REMARK 500 3 VAL B 519 -33.16 -137.91 REMARK 500 4 LEU A 4 -147.79 -103.40 REMARK 500 4 ASP A 20 95.07 -64.10 REMARK 500 4 SER A 38 -18.25 -47.87 REMARK 500 4 ASP A 64 -169.79 -103.69 REMARK 500 4 ASN A 97 -47.70 -139.21 REMARK 500 4 ASP A 131 -34.78 56.96 REMARK 500 4 ARG B 507 -44.51 -133.02 REMARK 500 4 ARG B 510 -32.36 -141.02 REMARK 500 4 GLU B 512 149.34 64.10 REMARK 500 4 LYS B 516 71.95 -65.36 REMARK 500 4 VAL B 517 -51.80 -158.34 REMARK 500 4 LEU B 518 -6.00 -56.58 REMARK 500 4 VAL B 519 -36.15 -134.70 REMARK 500 4 MET B 529 59.71 -108.89 REMARK 500 4 ARG B 530 -43.16 -130.35 REMARK 500 5 ASP A 2 124.43 62.86 REMARK 500 REMARK 500 THIS ENTRY HAS 247 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 30196 RELATED DB: BMRB REMARK 900 SOLUTION STRUCTURE OF THE CAM34 WITH THE INOS CAM BINDING DOMAIN REMARK 900 PEPTIDE REMARK 900 RELATED ID: 5TP5 RELATED DB: PDB DBREF 5TP6 A 1 148 UNP P62158 CALM_HUMAN 2 149 DBREF 5TP6 B 507 531 UNP P35228 NOS2_HUMAN 507 531 SEQADV 5TP6 ALA A 93 UNP P62158 ASP 94 ENGINEERED MUTATION SEQADV 5TP6 ALA A 129 UNP P62158 ASP 130 ENGINEERED MUTATION SEQADV 5TP6 ALA B 503 UNP P35228 EXPRESSION TAG SEQADV 5TP6 GLY B 504 UNP P35228 EXPRESSION TAG SEQADV 5TP6 HIS B 505 UNP P35228 EXPRESSION TAG SEQADV 5TP6 MET B 506 UNP P35228 EXPRESSION TAG SEQRES 1 A 148 ALA ASP GLN LEU THR GLU GLU GLN ILE ALA GLU PHE LYS SEQRES 2 A 148 GLU ALA PHE SER LEU PHE ASP LYS ASP GLY ASP GLY THR SEQRES 3 A 148 ILE THR THR LYS GLU LEU GLY THR VAL MET ARG SER LEU SEQRES 4 A 148 GLY GLN ASN PRO THR GLU ALA GLU LEU GLN ASP MET ILE SEQRES 5 A 148 ASN GLU VAL ASP ALA ASP GLY ASN GLY THR ILE ASP PHE SEQRES 6 A 148 PRO GLU PHE LEU THR MET MET ALA ARG LYS MET LYS ASP SEQRES 7 A 148 THR ASP SER GLU GLU GLU ILE ARG GLU ALA PHE ARG VAL SEQRES 8 A 148 PHE ALA LYS ASP GLY ASN GLY TYR ILE SER ALA ALA GLU SEQRES 9 A 148 LEU ARG HIS VAL MET THR ASN LEU GLY GLU LYS LEU THR SEQRES 10 A 148 ASP GLU GLU VAL ASP GLU MET ILE ARG GLU ALA ALA ILE SEQRES 11 A 148 ASP GLY ASP GLY GLN VAL ASN TYR GLU GLU PHE VAL GLN SEQRES 12 A 148 MET MET THR ALA LYS SEQRES 1 B 29 ALA GLY HIS MET ARG PRO LYS ARG ARG GLU ILE PRO LEU SEQRES 2 B 29 LYS VAL LEU VAL LYS ALA VAL LEU PHE ALA CYS MET LEU SEQRES 3 B 29 MET ARG LYS HELIX 1 AA1 THR A 5 ASP A 20 1 16 HELIX 2 AA2 THR A 29 ARG A 37 1 9 HELIX 3 AA3 SER A 38 GLY A 40 5 3 HELIX 4 AA4 GLU A 45 VAL A 55 1 11 HELIX 5 AA5 ASP A 64 LEU A 69 1 6 HELIX 6 AA6 ALA A 73 ASP A 78 1 6 HELIX 7 AA7 ASP A 80 ILE A 85 1 6 HELIX 8 AA8 ARG A 86 VAL A 91 1 6 HELIX 9 AA9 ALA A 103 GLY A 113 1 11 HELIX 10 AB1 THR A 117 GLU A 127 1 11 HELIX 11 AB2 ASN A 137 ALA A 147 1 11 HELIX 12 AB3 VAL B 519 PHE B 524 1 6 HELIX 13 AB4 ALA B 525 LEU B 528 5 4 SHEET 1 AA1 2 ILE A 27 THR A 28 0 SHEET 2 AA1 2 THR A 62 ILE A 63 -1 O ILE A 63 N ILE A 27 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1